Metabolomics Market worth $2,100 Million by 2019, According to a New Study on ASDReports

Friday 29 August 2014, Amsterdam

The new report, now available on ASDReports, “Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, by Application (Biomarker & Drug Discovery, Nutrigenomics), by Indication (Oncology, Cardiology) - Global Forecast to 2019” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World.

This report studies the metabolomics market over the forecast period of 2014 to 2019.

The technological progress in biochemistry and molecular biology has played a significant role in the development of the metabolomics market during the last decade. Also, the improvements in analytical instruments, and data processing and analysis software have contributed significantly in the advancement of the metabolomics field. The presence of research funding and government support for conducting research and commercialization of the products in the metabolomics market is the primary driver for the growth of this market. Metabolomics science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the metabolomics market. However, the lack of skilled professionals in metabolomics science is a significant restraint for the growth of the metabolomics market. The low adoption rate of metabolomics and data complexity are the other factors that are hindering the growth of the metabolomics market.

In this report, the metabolomics market is segmented based on techniques, applications, indications, geographic regions, and countries. This report also discusses the key market drivers, restraints, and opportunities for this market and its sub-markets. The global metabolomics market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019.

In 2013, North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

The major players in the metabolomics market include Thermo Fisher Scientific (U.S.), Metabolon, Inc. (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Agilent Technologies (U.S.), and Bruker Corporation (U.S.).